Roche Holding Overview

  • Founded
  • 1896
Founded
  • Status
  • Public
  • Employees
  • 101,465
Employees
  • Stock Symbol
  • ROG
Stock Symbol
  • Investments
  • 86
  • Share Price
  • $400.61
  • (As of Friday Closing)

Roche Holding General Information

Description

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 60% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Contact Information

Website
www.roche.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Drug Delivery
Stock Exchange
SWX
Primary Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland
+41 061 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Holding Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$400.61 $396.09 $320.21 - $419.90 $348B 854M 1.07M $18.04

Roche Holding Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 335,050,884 315,168,522 287,991,047 225,095,871
Revenue 65,644,637 62,111,160 61,855,068 58,089,107
EBITDA 25,020,873 24,557,779 21,734,711 18,877,989
Net Income 15,400,756 15,223,480 13,582,434 10,729,614
Total Assets 95,426,660 98,592,162 85,755,421 79,749,934
Total Debt 16,298,765 17,639,181 16,081,657 19,064,741
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Roche Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche Holding‘s full profile, request access.

Request a free trial

Roche Holding Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a var
Pharmaceuticals
Basel, Switzerland
101,465 As of 2020
00.000
00.00 0000-00-00
000000 - 000

00000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
000000000000000
Allschwil, Switzerland
0000 As of 0000
00000
00.00 0000-00-00
000000&0 00000

000000 0

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000000
Codolet, France
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Roche Holding Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Actelion Pharmaceuticals Formerly VC-backed Allschwil, Switzerland 0000 00000 000000&0 00000
000000 000000000 Formerly PE-Backed Codolet, France 000 000000&0
000000000000 Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0000000000.
000000 00000 Corporation Mumbai, India 0000
0000000000 0000000 Corporation Ingelheim am Rhein, Germany 00000
You’re viewing 5 of 18 competitors. Get the full list »

Roche Holding Patents

Roche Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200399274-A1 Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereof Pending 08-Jun-2020 0000000000
US-20200399275-A1 Pyrazolopyrimidine sulfone inhibitors of jak kinases and uses thereof Pending 05-Jun-2020 0000000000
EP-3901152-A1 Kv3 enhancers for the treatment of cognitive disorders Pending 23-Apr-2020 0000000000
EP-3901152-A4 Kv3 enhancers for the treatment of cognitive disorders Pending 23-Apr-2020 0000000000
EP-3901155-A4 New benzodiazepine derivatives as gaba a gamma1 pam Pending 20-Apr-2020 C07D487/04
To view Roche Holding’s complete patent history, request access »

Roche Holding Executive Team (40)

Name Title Board Seat Contact Info
Severin Schwan Chief Executive Officer & Member of the Board of Directors
Alan Hippe JD Chief Financial & Information Officer
James Sabry Ph.D Managing Director & Global Head
Cristina Wilbur Chief People Officer & Board Member
Frank Fanien Ph.D Head of Digital Health Solutions Roche Diagnostics CPS & Senior Vice President
You’re viewing 5 of 40 executive team members. Get the full list »

Roche Holding Board Members (18)

Name Representing Role Since
00000 00000000 Self Board Member & Vice Chairman 000 0000
0000é 00000000 Roche Holding Vice Chairman 000 0000
0000000 0000 Roche Holding Board Member 000 0000
00000 000000 Self Board Member 000 0000
0000000 0000000 Roche Holding Board Member 000 0000
You’re viewing 5 of 18 board members. Get the full list »

Roche Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roche Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche Holding‘s full profile, request access.

Request a free trial

Roche Holding Investments & Acquisitions (86)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 0000000 0 01-Dec-2021 0000000000 Biotechnology 000000 00
0000000 00000 22-Apr-2021 0000000000 00.00 Diagnostic Equipment
00000 000000 01-Dec-2020 00000 0000 000.00 Drug Discovery
0000000000 00 06-Oct-2020 000000000 000.00 Drug Discovery
Enterprise Therapeutics (TMEM16A Potentiator Portfolio) 06-Oct-2020 Corporate Asset Purchase 000.00 Buildings and Property 00000 000
You’re viewing 5 of 86 investments and acquisitions. Get the full list »

Roche Holding Subsidiaries (21)

Company Name Industry Location Founded
Spark Therapeutics Biotechnology Philadelphia, PA 2013
00000000 Enterprise Systems (Healthcare) New York, NY 0000
000000 Information Services (B2C) Vienna, Austria 0000
0000000000 0000000 Diagnostic Equipment Cambridge, MA 0000
0000000 0000000000 Diagnostic Equipment Carlsbad, CA 0000
You’re viewing 5 of 21 subsidiaries. Get the full list »

Roche Holding Exits (18)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 00000000000 12-Jan-2015 000000000000000000 00000 Completed
  • 00000 0000000
0000000 24-Sep-2014 00000 00000 00 0000 Completed
  • 9 buyers
000000 18-Jun-2014 000000000 00000 00 00.000 Completed
  • 00000 0000000
000000000 00000000 17-Dec-2012 000000000 Completed
  • 00000 0000000
cCAM Biotherapeutics 14-Sep-2012 Early Stage VC 000 Completed
  • 6 buyers
You’re viewing 5 of 18 exits. Get the full list »